860649P

C24 Ceramide (d17:1/24:0)

Avanti Research^™ - A Croda Brand 860649P, powder

• Synonym(e): N-lignoceroyl-D-erythro-sphingosine (C17 base)
• Empirische Formel (Hill-System): C₄₁H₈₁NO₃
• CAS-Nummer: 123065-50-9
• Molekulargewicht: 636.09
• UNSPSC-Code: 12352211
• NACRES: NA.25

Eigenschaften

• Form: powder
• Verpackung: pkg of 1 × 10 mg (860649P-10mg)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand 860649P
• Lipid-Typ: sphingolipids
• Versandbedingung: dry ice
• Lagertemp.: −20°C
• SMILES String: OC[C@]([H])(NC(CCCCCCCCCCCCCCCCCCCCCCC)=O)[C@]([H])(O)/C=C/CCCCCCCCCCCC

Beschreibung

Allgemeine Beschreibung

C24 Ceramide (d17:1/24:0) is a synthetic ceramide derived from a C17 sphingosine with lignoceric acid. Ceramide synthase 2 is responsible for the synthesis of C24 ceramide.

Anwendung

C24 Ceramide (d17:1/24:0) has been used as an internal standard to quantify ceramide content in both subcutaneous and visceral adipose tissue by ultraperformance liquid chromatography - tandem mass spectrometery (UPLC-MS/MS).

Biochem./physiol. Wirkung

C24 Ceramide (d17:1/24:0) plays a vital role in inducing cell death. Altered levels of C24 Ceramide might be a potential indication in tumor monitoring.

Verpackung

5 mL Amber Glass Screw Cap Vial (860649P-10mg)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable